Endometrial cancer trials in Spain

In Spain 53 Also abroad 395

53 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 12 November 2026. Ask the study team whether a trial fits you.

Phase 2/3Taking people
A clinical study of MK-5684 in people with certain solid tumors (MK-5684-015)
Where
A Coruña, L'Hospitalet de Llobregat, Madrid, Pozuelo de Alarcón
Age
18 years and over
People
22
Run by
Merck Sharp & Dohme LLC
See details and how to join2024-519563-18-00
Phase 1/2Taking people
Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers
Where
Badalona, Barcelona, Girona, Madrid, Santiago de Compostela
Age
18 years and over
People
890 worldwide
Run by
Regeneron Pharmaceuticals
See details and how to joinNCT03564340 · EU 2024-510783-23-00
Phase 1/2Taking people
A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
Where
Girona, Madrid, Santiago de Compostela
Age
18 years and over
People
612 worldwide
Run by
Regeneron Pharmaceuticals
See details and how to joinNCT04590326 · EU 2022-501904-83-00
No phaseTaking people
Prognosis and Therapeutic Implications in Molecular High-Risk Non-Myoinvasive Endometrial Cancer
Where
Barcelona
Age
18 years and over
People
350
Run by
Hospital Universitari Vall d'Hebron Research Institute
See details and how to joinNCT07838207
Phase 2Taking people
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
Where
Barcelona, Córdoba, Madrid, Málaga, Sevilla
Age
18 years to 130 years
People
454 worldwide
Run by
AstraZeneca
See details and how to joinNCT05489211 · EU 2023-509436-26-00
Phase 1/2Taking people
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Where
Barcelona, Madrid, Pamplona, Seville, Valencia, Zaragoza
Age
18 years and over
People
534 worldwide
Run by
Revolution Medicines, Inc.
See details and how to joinNCT06128551
Phase 1Taking people
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Where
Barcelona, Madrid, Piqueras, Seville
Age
18 years and over
People
540 worldwide
Run by
SystImmune Inc.
See details and how to joinNCT05983432
Phase 1/2Taking people
A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors
Where
Barcelona, Madrid
Age
18 years and over
People
47 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT07213609
No phaseTaking people
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Where
A Coruña, Barcelona, Girona, Las Palmas de Gran Canaria, Madrid, Málaga, Sabadell, Santiago de Compostela, Valencia
Age
18 years and over
People
2,285 worldwide
Run by
Guardant Health, Inc.
See details and how to joinNCT05059444
No phaseTaking people
Pelvic Ultra-Hypofractionated Adjuvant Radiotherapy for Endometrial Cancer (PURE-cohort)
Where
Zaragoza
Age
18 years to 110 years
People
50
Run by
Instituto de Investigación Sanitaria Aragón
See details and how to joinNCT07779109
Phase 2Taking people
A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
Where
Barcelona, L'Hospitalet de Llobregat, Madrid, Majadahonda, Valencia
Age
18 years and over
People
350 worldwide
Run by
Acrivon Therapeutics
See details and how to joinNCT05548296 · EU 2025-524542-10-00
Phase 1Taking people
A Study to Test How Well Different Doses of BI 3820768 Are Tolerated by People With Advanced Cancer (Solid Tumours)
Where
Barcelona, Madrid
Age
18 years and over
People
187 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT07306559 · EU 2025-522913-45-00
Phase 1/2Taking people
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
Where
Barcelona, Girona, Madrid, Majadahonda, Palma, Pamplona, Pozuelo de Alarcón, Sabadell, Salamanca, Santiago de Compostela, Sevilla, Valencia
Age
18 years and over
People
300 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT04104776 · EU 2023-508002-20-00
Phase 1/2Taking people
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Where
Barcelona, Madrid, Valencia
Age
18 years and over
People
366 worldwide
Run by
Marengo Therapeutics, Inc.
See details and how to joinNCT05592626 · EU 2023-505334-10-01
Phase 3Taking people
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator’s Choice in Participants With Endometrial Cancer ( RAINFOL-03 )
Where
A Coruña, Barcelona, Girona, Madrid, Málaga, Palma, Pamplona, Sevilla, Valencia, Zaragoza
Age
18 years and over
People
290 worldwide
Run by
Genmab A/S
See details and how to join2024-519818-31-01
Phase 3Taking people
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
Where
Badalona, Barcelona, Córdoba, L'Hospitalet de Llobregat, Madrid, Málaga, Murcia, Oviedo, Santiago de Compostela, Sevilla, Valencia
Age
18 years and over
People
800 worldwide
Run by
AstraZeneca
See details and how to joinNCT07044336 · EU 2024-518777-34-00
Phase 1Taking people
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Where
Barcelona, L'Hospitalet de Llobregat, Madrid
Age
18 years and over
People
714 worldwide
Run by
Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT05208762 · EU 2023-506604-18-00
Phase 2Taking people
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Where
Badalona, Barcelona, Madrid, Valencia
Age
18 years and over
People
270 worldwide
Run by
Corcept Therapeutics
See details and how to joinNCT06906341
Phase 1/2Taking people
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Where
Barcelona, Logroño, Madrid, Pozuelo de Alarcón, Reus, Sevilla
Age
18 years and over
People
880 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT05768139 · EU 2023-504807-94-00
Phase 1/2Taking people
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
Where
Badalona, Barcelona, Valencia
Age
18 years and over
People
182 worldwide
Run by
Eisai Inc.
See details and how to joinNCT04300556 · EU 2023-506868-14-00
No phaseTaking people
Performance of SYMMCORA® vs. V-Loc® Suture Material in Patients Undergoing Laparoscopic Total Hysterectomy
Where
Manresa
Age
18 years and over
People
132 worldwide
Run by
Aesculap AG
See details and how to joinNCT06024109
Phase 2Taking people
Single cEll pRofiling PErsistaNce To ImmuNothErapy
Where
Barcelona
Age
18 years and over
People
60
Run by
Vall d'Hebron Institute of Oncology
See details and how to joinNCT06680739
Phase 1Taking people
A Phase I Interventional Open-label, Non-randomized Dose-escalation Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity, and Preliminary Anti-tumor Activity of Autologous p95HER2.CAR-TECH2Me T Cells in Patients With Selected Advanced Cancers.
Where
Barcelona
Age
18 years and over
People
15
Run by
Vall d'Hebron Institute of Oncology
See details and how to joinNCT07593820 · EU 2024-516660-28-01
Phase 2Taking people
A basket study to investigate the efficacy and safety of SKB264 in combination with pembrolizumab in subjects with solid tumors
Where
Barcelona, Madrid, Santiago de Compostela, Sevilla, Valencia
Age
18 years and over
People
101 worldwide
Run by
Sichuan Kelun-Biotech Biopharmaceutical Co. Ltd.
See details and how to joinNCT05642780 · EU 2022-502654-14-00
No phaseTaking people
Outcomes of Low-Risk Endometrial Cancer With Isolated Tumor Cells in the Sentinel Lymph Nodes: A Prospective, Multicenter, Single-Arm Observational Study
Where
Las Palmas, Madrid
People
212 worldwide
Run by
Mayo Clinic
See details and how to joinNCT06689956